drugset / Trial / NCT01047241

Nasal Administration of Sufentanil+Ketamine for Procedure-related Pain in Children

NCT01047241

NaSingle-groupOpen-labelTreatment

Summary

The aim of the study is to investigate the absorption and clinical effect of nasal administration of an analgesic nasal spray containing sufentanil+ketamine for pain related to medical procedures in hospitalized children.

Timeline

Start
2010-04
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intranasal
Subject Sufentanil Other / unclassified 0.5 ug/kg Intranasal

Indications

No indication recorded.